Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfred Yung

Showing results (21-30 of 217) with videos related to

Pageof 22
Sort By:
Neuro-Oncology|December 16, 2006
Mapping the future of Neuro-OncologyW K Alfred Yung, C David James
International Journal of Molecular Sciences|January 5, 2021
Molecular Mechanisms of Treatment Resistance in GlioblastomaAlexander Ou, W K Alfred Yung, Nazanin Majd
Cancer Journal (Sudbury, Mass.)|October 7, 2008
Bevacizumab and irinotecan in the treatment of recurrent malignant gliomasJohn F de Groot, Wai Kwan Alfred Yung
Archives of Neurology|November 10, 2010
Advances in translational research in neuro-oncologyJuan Fueyo, Candelaria Gomez-Manzano, W K Alfred Yung
Cell Cycle (Georgetown, Tex.)|January 24, 2009
Inhibiting PI-3-K for glioma therapyGarth Powis, Nathan T Ihle, W K Alfred Yung
Cancer Research|March 26, 2002
VEGF(121), VEGF(165) overexpression enhances tumorigenicity in U251 MG but not in NG-1 glioma cellsLi Dao Ke, Yue-Xi Shi, W K Alfred Yung
Breast Cancer Research : BCR|September 20, 2005
Se-methylselenocysteine inhibits phosphatidylinositol 3-kinase activity of mouse mammary epithelial tumor cells in vitroEmmanual Unni, Dimpy Koul, Wai-Kwan Alfred Yung, et al.
Cancer Investigation|April 9, 2005
Benefit of temozolomide compared to procarbazine in treatment of glioblastoma multiforme at first relapse: effect on neurological functioning, performance status, and health related quality of lifeDavid R Macdonald, Gwendoline Kiebert, Michael Prados, et al.
Neurology|August 12, 2004
Genetically modified adenoviruses against gliomas: from bench to bedsideCandelaria Gomez-Manzano, W K Alfred Yung, Ramon Alemany, et al.
Neuro-Oncology|December 3, 2010
AMPK/TSC2/mTOR-signaling intermediates are not necessary for LKB1-mediated nuclear retention of PTEN tumor suppressorJuinn-Lin Liu, Zhenyu Mao, Gary E Gallick, et al.
Pageof 22

Showing results (21-30 of 217) with videos related to

Sort By:
Pageof 22
Neuro-Oncology|December 16, 2006
Mapping the future of Neuro-OncologyW K Alfred Yung, C David James
International Journal of Molecular Sciences|January 5, 2021
Molecular Mechanisms of Treatment Resistance in GlioblastomaAlexander Ou, W K Alfred Yung, Nazanin Majd
Cancer Journal (Sudbury, Mass.)|October 7, 2008
Bevacizumab and irinotecan in the treatment of recurrent malignant gliomasJohn F de Groot, Wai Kwan Alfred Yung
Archives of Neurology|November 10, 2010
Advances in translational research in neuro-oncologyJuan Fueyo, Candelaria Gomez-Manzano, W K Alfred Yung
Cell Cycle (Georgetown, Tex.)|January 24, 2009
Inhibiting PI-3-K for glioma therapyGarth Powis, Nathan T Ihle, W K Alfred Yung
Cancer Research|March 26, 2002
VEGF(121), VEGF(165) overexpression enhances tumorigenicity in U251 MG but not in NG-1 glioma cellsLi Dao Ke, Yue-Xi Shi, W K Alfred Yung
Breast Cancer Research : BCR|September 20, 2005
Se-methylselenocysteine inhibits phosphatidylinositol 3-kinase activity of mouse mammary epithelial tumor cells in vitroEmmanual Unni, Dimpy Koul, Wai-Kwan Alfred Yung, et al.
Cancer Investigation|April 9, 2005
Benefit of temozolomide compared to procarbazine in treatment of glioblastoma multiforme at first relapse: effect on neurological functioning, performance status, and health related quality of lifeDavid R Macdonald, Gwendoline Kiebert, Michael Prados, et al.
Neurology|August 12, 2004
Genetically modified adenoviruses against gliomas: from bench to bedsideCandelaria Gomez-Manzano, W K Alfred Yung, Ramon Alemany, et al.
Neuro-Oncology|December 3, 2010
AMPK/TSC2/mTOR-signaling intermediates are not necessary for LKB1-mediated nuclear retention of PTEN tumor suppressorJuinn-Lin Liu, Zhenyu Mao, Gary E Gallick, et al.
Pageof 22